Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
American Journal of Cancer Research
|
April 13, 2017
A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma
Chun-Te Chen, Yi-Chun Chen, Yi Du, et al.
The Journal of Clinical Investigation
|
April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
Gastroenterology
|
February 4, 2019
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Hui Li, Chia-Wei Li, Xiaoqiang Li, et al.
Oncoimmunology
|
April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission
Jennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.
Nature
|
May 3, 2013
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Jia Shen, Weiya Xia, Yekaterina B Khotskaya, et al.
EMBO Molecular Medicine
|
March 26, 2013
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
Yung-Luen Yu, Ruey-Hwang Chou, Woei-Cherng Shyu, et al.
Journal of Hepatology
|
October 8, 2020
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma
Chunxiao Liu, Zhengyu Zha, Chenhao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 8, 2017
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, et al.
American Journal of Translational Research
|
August 18, 2015
Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers
Cheng-Chieh Yang, Adam LaBaff, Yongkun Wei, et al.
Oncotarget
|
August 6, 2016
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers
How-Wen Ko, Heng-Huan Lee, Longfei Huo, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
American Journal of Cancer Research
|
April 13, 2017
A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma
Chun-Te Chen, Yi-Chun Chen, Yi Du, et al.
The Journal of Clinical Investigation
|
April 15, 2021
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang, Seung-Oe Lim, Meisi Yan, et al.
Gastroenterology
|
February 4, 2019
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1
Hui Li, Chia-Wei Li, Xiaoqiang Li, et al.
Oncoimmunology
|
April 11, 2018
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission
Jennifer L Hsu, Christian E Bryant, Michael S Papadimitrious, et al.
Nature
|
May 3, 2013
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Jia Shen, Weiya Xia, Yekaterina B Khotskaya, et al.
EMBO Molecular Medicine
|
March 26, 2013
Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke
Yung-Luen Yu, Ruey-Hwang Chou, Woei-Cherng Shyu, et al.
Journal of Hepatology
|
October 8, 2020
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma
Chunxiao Liu, Zhengyu Zha, Chenhao Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 8, 2017
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao, Weiya Xia, Hirohito Yamaguchi, et al.
American Journal of Translational Research
|
August 18, 2015
Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers
Cheng-Chieh Yang, Adam LaBaff, Yongkun Wei, et al.
Oncotarget
|
August 6, 2016
GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers
How-Wen Ko, Heng-Huan Lee, Longfei Huo, et al.
Page
of 11